Mass General Brigham Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
+$149K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$16.7M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$8.75M |
| 3 |
Airbnb
ABNB
|
+$522K |
| 4 |
DADA
Dada Nexus
DADA
|
+$1K |
| 5 |
DOCU
DocuSign
DOCU
|
+$1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 10.41% |
| 2 | Consumer Discretionary | 0% |
| 3 | Healthcare | 0% |
| 4 | Technology | 0% |
Similar funds
Mass General Brigham's Q1 2022 Portfolio in Review
As of Q1 2022, Mass General Brigham held 8 positions worth $235M, down 17% from $282M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Mass General Brigham withdrew a net $25.8M in Q1 2022, closing 3 positions and reducing 3 holdings. Its most notable exit was DocuSign, an estimated $1K position sold in full.
By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Mass General Brigham opened a new position in Jounce Therapeutics, Inc. Common Stock worth $1K.
- Mass General Brigham's largest Q1 2022 buy was Jounce Therapeutics, Inc. Common Stock: 20,957 shares worth $1K.
- Mass General Brigham's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $16.7M.
- Mass General Brigham fully exited DocuSign in Q1 2022, selling an estimated $1K.
- Mass General Brigham's ten largest holdings make up 100% of its $235M portfolio in Q1 2022.
- Mass General Brigham opened 1 new position and closed 3 in Q1 2022.
- Mass General Brigham's portfolio value fell 17% quarter-over-quarter to $235M.
Based on Mass General Brigham's 13F filing for Q1 2022, filed 15 Apr 2022.